These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23469976

  • 1. HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin.
    Cui Y, Wu W, Zhou Y, Xie Q, Liu T, Jin J, Liu K.
    Future Oncol; 2013 Mar; 9(3):411-8. PubMed ID: 23469976
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V, Sausville EA, Camalier RF, Fiebig HH, Burger AM.
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [Abstract] [Full Text] [Related]

  • 3. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
    Belkacemi L, Hebb MO.
    Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
    [Abstract] [Full Text] [Related]

  • 4. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
    Lamoureux F, Thomas C, Yin MJ, Fazli L, Zoubeidi A, Gleave ME.
    Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.
    Liu H, Zhang T, Chen R, McConkey DJ, Ward JF, Curley SA.
    J Surg Res; 2012 Jul; 176(1):147-53. PubMed ID: 22099584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Maloney A, Clarke PA, Naaby-Hansen S, Stein R, Koopman JO, Akpan A, Yang A, Zvelebil M, Cramer R, Stimson L, Aherne W, Banerji U, Judson I, Sharp S, Powers M, deBilly E, Salmons J, Walton M, Burlingame A, Waterfield M, Workman P.
    Cancer Res; 2007 Apr 01; 67(7):3239-53. PubMed ID: 17409432
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.
    McCollum AK, Teneyck CJ, Sauer BM, Toft DO, Erlichman C.
    Cancer Res; 2006 Nov 15; 66(22):10967-75. PubMed ID: 17108135
    [Abstract] [Full Text] [Related]

  • 12. [Influence of 17AAG on proliferation and invasion of gastric cancer cell and its mechanism].
    Cui Y, Yu Y, Liu T, Xie Q, Wu W, Liu K.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct 15; 17(10):1031-5. PubMed ID: 25341914
    [Abstract] [Full Text] [Related]

  • 13. p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Fujii Y, Kato T, Kubota N, Fujimori A, Niwa O, Okayasu R.
    Oncol Rep; 2010 Jan 15; 23(1):199-203. PubMed ID: 19956882
    [Abstract] [Full Text] [Related]

  • 14. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM, Liu T, Yang J, Cui JF, Li XH, Zhu YN, Xiong T, Zhang G, Chen Y.
    Cell Biol Int; 2012 Oct 01; 36(10):893-9. PubMed ID: 22694478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
    McCollum AK, TenEyck CJ, Stensgard B, Morlan BW, Ballman KV, Jenkins RB, Toft DO, Erlichman C.
    Cancer Res; 2008 Sep 15; 68(18):7419-27. PubMed ID: 18794130
    [Abstract] [Full Text] [Related]

  • 17. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells.
    Liu X, Ban LL, Luo G, Li ZY, Li YF, Zhou YC, Wang XC, Jin CG, Ye JG, Ma DD, Xie Q, Huang YG.
    Anticancer Drugs; 2016 Jun 15; 27(5):417-26. PubMed ID: 26872308
    [Abstract] [Full Text] [Related]

  • 18. Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells.
    Siegel D, Shieh B, Yan C, Kepa JK, Ross D.
    J Pharmacol Exp Ther; 2011 Mar 15; 336(3):874-80. PubMed ID: 21156818
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
    Chen JC, Ko JC, Taso YC, Cheng HH, Chen TY, Yen TC, Lin YW.
    Pharmacology; 2021 Mar 15; 106(3-4):154-168. PubMed ID: 33202406
    [Abstract] [Full Text] [Related]

  • 20. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
    Chung YL, Troy H, Banerji U, Jackson LE, Walton MI, Stubbs M, Griffiths JR, Judson IR, Leach MO, Workman P, Ronen SM.
    J Natl Cancer Inst; 2003 Nov 05; 95(21):1624-33. PubMed ID: 14600095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.